New and Improved Neocate Infant

As part of Nutricia North America’s commitment to specialized nutrition we are continuing to make improvements across our Neocate family of products in order to provide your child with the best possible nutritional support according to the latest medical and scientific knowledge. Starting mid-August 2013 we are very excited to announce the availability of our new and improved Neocate Infant DHA/ARA.

These new improvements will include:

  • Optimized nutrient levels (for example, higher Vitamin D) to better meet infant nutrient needs based on current science
  • The addition of nucleotides, important nutrients naturally found in breastmilk (please note: the addition of nucleotides and adjustments to nutrient levels will not affect hypoallergenicity)
  • Removed soy oil making Neocate Infant DHA/ARA the only elemental infant formula that does not contain soy oil
  • Simplified 1:1 mixing with easy and flexible serving sizes

Neocate Infant DHA/ARA continues to be the same trusted hypoallergenic, amino acid-based formula suitable for the dietary management of cow and soy milk allergies, multiple food protein intolerance, eosinophilic esophagitis, short bowel syndrome and other conditions requiring an elemental diet. We look forward to bringing you the best clinical nutrition products. If you have any questions, please contact our Nutrition Support Department toll-free at 1-800-365-7354. You can also follow us on Twitter @Neocate or like our Facebook page to stay up to date on the latest news.


Join Neocate Footsteps

Whether you are new to food allergies and want to get to know our products, or you need help with a lifestyle change, for new ideas to .

Join Neocate Footsteps

Featured Article
It’s Here! Announcing the Newly Redesigned!

Neocate® is proud to launch our newly redesigned The new website has been rebuilt with you in mind: Organized – quickly find key information for your food allergy journey Customized – flexibility to tailor to your needs: see content…

Continue Reading
Related News

The content you are trying to access is intended for healthcare professionals only.

Are you a healthcare professional?